drugset / Trial / NCT00404612
A Study of LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective of this study is to evaluate the safety and efficacy of LX211 as therapy in subjects with active non-infectious uveitis
Timeline
- Start
- 2007-01
- Primary completion
- 2008-11
- Completion
- 2009-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Voclosporin | Other / unclassified | 0.2 mg/kg | — |
| Comparator | Voclosporin | Other / unclassified | 0.4 mg/kg | — |
| Comparator | Voclosporin | Other / unclassified | 0.6 mg/kg | — |